| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | mRNA binding | CASC3 FXR1 G3BP1 ATXN2 SUPT5H RBMX NCL TAF15 DHX33 MBD2 MECP2 CHTOP METTL14 | 1.36e-08 | 694 | 51 | 13 | GO:0003729 |
| GeneOntologyMolecularFunction | molecular condensate scaffold activity | 3.93e-06 | 42 | 51 | 4 | GO:0140693 | |
| GeneOntologyMolecularFunction | methyl-CpG binding | 6.71e-05 | 31 | 51 | 3 | GO:0008327 | |
| GeneOntologyMolecularFunction | PH domain binding | 2.28e-04 | 9 | 51 | 2 | GO:0042731 | |
| GeneOntologyMolecularFunction | siRNA binding | 4.15e-04 | 12 | 51 | 2 | GO:0035197 | |
| GeneOntologyMolecularFunction | chromatin binding | 5.27e-04 | 739 | 51 | 8 | GO:0003682 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 6.51e-04 | 417 | 51 | 6 | GO:0140098 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 1.04e-03 | 78 | 51 | 3 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 1.12e-03 | 80 | 51 | 3 | GO:0008186 | |
| GeneOntologyBiologicalProcess | RNA localization | 1.37e-05 | 217 | 50 | 6 | GO:0006403 | |
| GeneOntologyBiologicalProcess | RNA transport | 6.46e-05 | 175 | 50 | 5 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 6.46e-05 | 175 | 50 | 5 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 7.00e-05 | 178 | 50 | 5 | GO:0051236 | |
| GeneOntologyBiologicalProcess | retrograde neuronal dense core vesicle transport | 8.59e-05 | 6 | 50 | 2 | GO:1990049 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 9.05e-05 | 443 | 50 | 7 | GO:1903311 | |
| GeneOntologyBiologicalProcess | anterograde neuronal dense core vesicle transport | 1.60e-04 | 8 | 50 | 2 | GO:1990048 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 1.66e-04 | 44 | 50 | 3 | GO:0048026 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 1.73e-04 | 115 | 50 | 4 | GO:1903312 | |
| GeneOntologyBiologicalProcess | RNA splicing | 1.96e-04 | 502 | 50 | 7 | GO:0008380 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 2.19e-04 | 358 | 50 | 6 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 2.19e-04 | 358 | 50 | 6 | GO:0000377 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 2.28e-04 | 49 | 50 | 3 | GO:0050685 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 2.32e-04 | 362 | 50 | 6 | GO:0000375 | |
| GeneOntologyBiologicalProcess | nuclear pore complex assembly | 3.12e-04 | 11 | 50 | 2 | GO:0051292 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 3.35e-04 | 249 | 50 | 5 | GO:0015931 | |
| GeneOntologyBiologicalProcess | dense core granule cytoskeletal transport | 3.74e-04 | 12 | 50 | 2 | GO:0099519 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 4.01e-04 | 259 | 50 | 5 | GO:1903313 | |
| GeneOntologyBiologicalProcess | mRNA transport | 4.20e-04 | 145 | 50 | 4 | GO:0051028 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 4.80e-04 | 63 | 50 | 3 | GO:0033120 | |
| GeneOntologyBiologicalProcess | dense core granule transport | 5.14e-04 | 14 | 50 | 2 | GO:1901950 | |
| GeneOntologyBiologicalProcess | nuclear pore organization | 8.60e-04 | 18 | 50 | 2 | GO:0006999 | |
| GeneOntologyBiologicalProcess | nuclear export | 1.05e-03 | 185 | 50 | 4 | GO:0051168 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | CASC3 RBMXL1 SUPT5H RBMX LSM4 E2F3 NCL MBD2 CCDC9 CHTOP NUP153 CREBZF RING1 | 1.87e-05 | 1377 | 51 | 13 | GO:0140513 |
| GeneOntologyCellularComponent | supraspliceosomal complex | 3.49e-05 | 4 | 51 | 2 | GO:0044530 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 4.76e-05 | 269 | 51 | 6 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 6.81e-05 | 287 | 51 | 6 | GO:0035770 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 8.85e-05 | 96 | 51 | 4 | GO:0010494 | |
| GeneOntologyCellularComponent | dense fibrillar component | 1.22e-04 | 7 | 51 | 2 | GO:0001651 | |
| GeneOntologyCellularComponent | spliceosomal complex | 1.76e-04 | 215 | 51 | 5 | GO:0005681 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | 5.32e-04 | 1194 | 51 | 10 | GO:1990904 | |
| GeneOntologyCellularComponent | exon-exon junction complex | 1.19e-03 | 21 | 51 | 2 | GO:0035145 | |
| GeneOntologyCellularComponent | heterochromatin | 1.93e-03 | 101 | 51 | 3 | GO:0000792 | |
| HumanPheno | Abnormal superficial reflex | 8.12e-05 | 301 | 14 | 6 | HP:0031828 | |
| HumanPheno | Babinski sign | 8.12e-05 | 301 | 14 | 6 | HP:0003487 | |
| HumanPheno | Lower limb hyperreflexia | 8.69e-05 | 92 | 14 | 4 | HP:0002395 | |
| HumanPheno | Cachexia | 1.20e-04 | 100 | 14 | 4 | HP:0004326 | |
| HumanPheno | Abnormal tongue physiology | 2.07e-04 | 115 | 14 | 4 | HP:0030810 | |
| Domain | Methyl_CpG_DNA-bd | 2.93e-06 | 11 | 50 | 3 | IPR001739 | |
| Domain | MBD | 2.93e-06 | 11 | 50 | 3 | PF01429 | |
| Domain | MBD | 2.93e-06 | 11 | 50 | 3 | SM00391 | |
| Domain | MBD | 2.93e-06 | 11 | 50 | 3 | PS50982 | |
| Domain | DNA-bd_dom | 2.93e-06 | 11 | 50 | 3 | IPR016177 | |
| Domain | RRM_1 | 1.87e-05 | 208 | 50 | 6 | PF00076 | |
| Domain | RRM | 2.38e-05 | 217 | 50 | 6 | SM00360 | |
| Domain | zf-RanBP | 2.68e-05 | 22 | 50 | 3 | PF00641 | |
| Domain | RRM_dom | 3.07e-05 | 227 | 50 | 6 | IPR000504 | |
| Domain | ZnF_RBZ | 3.08e-05 | 23 | 50 | 3 | SM00547 | |
| Domain | RRM_dom_euk | 3.08e-05 | 23 | 50 | 3 | IPR003954 | |
| Domain | RRM_1 | 3.08e-05 | 23 | 50 | 3 | SM00361 | |
| Domain | ZF_RANBP2_2 | 3.08e-05 | 23 | 50 | 3 | PS50199 | |
| Domain | RRM | 3.30e-05 | 230 | 50 | 6 | PS50102 | |
| Domain | ZF_RANBP2_1 | 3.51e-05 | 24 | 50 | 3 | PS01358 | |
| Domain | Znf_RanBP2 | 3.98e-05 | 25 | 50 | 3 | IPR001876 | |
| Domain | - | 4.59e-05 | 244 | 50 | 6 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 6.26e-05 | 258 | 50 | 6 | IPR012677 | |
| Domain | HMGI/Y_DNA-bd_CS | 7.70e-05 | 31 | 50 | 3 | IPR000637 | |
| Domain | RBM1CTR | 1.95e-04 | 8 | 50 | 2 | PF08081 | |
| Domain | RBM1CTR | 1.95e-04 | 8 | 50 | 2 | IPR012604 | |
| Domain | - | 1.95e-04 | 8 | 50 | 2 | 3.30.890.10 | |
| Domain | - | 3.12e-04 | 10 | 50 | 2 | 4.10.1060.10 | |
| Domain | DUF1605 | 9.31e-04 | 17 | 50 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 9.31e-04 | 17 | 50 | 2 | PF07717 | |
| Domain | HA2 | 1.05e-03 | 18 | 50 | 2 | PF04408 | |
| Domain | Helicase-assoc_dom | 1.05e-03 | 18 | 50 | 2 | IPR007502 | |
| Domain | HA2 | 1.05e-03 | 18 | 50 | 2 | SM00847 | |
| Domain | LSM_dom | 1.57e-03 | 22 | 50 | 2 | IPR010920 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 3.95e-03 | 35 | 50 | 2 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 4.64e-03 | 38 | 50 | 2 | PS00690 | |
| Pathway | WP_MRNA_PROCESSING | 9.28e-09 | 451 | 36 | 11 | MM15946 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 1.70e-05 | 612 | 36 | 9 | MM15547 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 6.36e-05 | 724 | 36 | 9 | M16843 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 6.47e-05 | 277 | 36 | 6 | MM15414 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 7.28e-05 | 283 | 36 | 6 | M13087 | |
| Pathway | BIOCARTA_SARS_PATHWAY | 1.32e-04 | 7 | 36 | 2 | M5374 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | CASC3 NOP9 FXR1 ILF2 G3BP1 ATXN2 FBL SUPT5H NOM1 RBMX DHX57 LSM4 EWSR1 NCL TAF15 CCDC9 CHTOP PURG KIF1C LRRC47 | 1.02e-19 | 807 | 52 | 20 | 22681889 |
| Pubmed | NOP9 FXR1 ILF2 G3BP1 FBL SUPT5H RBMX DHX57 LSM4 EWSR1 NCL TAF15 MECP2 CCDC9 METTL14 RING1 | 5.34e-15 | 723 | 52 | 16 | 34133714 | |
| Pubmed | FXR1 ILF2 G3BP1 RBMXL1 FBL RBMX LSM4 EWSR1 NCL TMEM214 TAF15 ERMP1 CHTOP LRRC47 RING1 | 8.75e-14 | 711 | 52 | 15 | 33022573 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOP9 ILF2 FBL SUPT5H NOM1 RBMX LSM4 EWSR1 NCL TMEM214 TAF15 DHX33 MBD2 MECP2 CHTOP NUP153 RING1 | 2.90e-12 | 1294 | 52 | 17 | 30804502 |
| Pubmed | CASC3 FXR1 ILF2 G3BP1 ATXN2 FBL NOM1 RBMX DHX57 EWSR1 NCL TAF15 MBD2 MECP2 CHTOP LRRC47 RING1 | 7.22e-12 | 1371 | 52 | 17 | 36244648 | |
| Pubmed | CASC3 ZNF469 NOP9 FXR1 ILF2 G3BP1 SUPT5H RBMX DHX57 EWSR1 TAF15 CCDC9 CHTOP | 1.04e-11 | 653 | 52 | 13 | 33742100 | |
| Pubmed | IRS4 FXR1 ILF2 G3BP1 FBL SUPT5H RBMX DHX57 EWSR1 NCL TAF15 NUP153 LRRC47 | 1.04e-11 | 653 | 52 | 13 | 22586326 | |
| Pubmed | IRS4 FXR1 ILF2 G3BP1 ATXN2 RBMX EWSR1 NCL TAF15 TUSC1 CCDC9 CHTOP | 2.58e-11 | 551 | 52 | 12 | 34728620 | |
| Pubmed | CASC3 FXR1 ILF2 G3BP1 RBMXL1 ATXN2 FBL RBMX DHX57 LSM4 NCL TAF15 CHTOP | 3.09e-11 | 713 | 52 | 13 | 29802200 | |
| Pubmed | 4.56e-11 | 441 | 52 | 11 | 31239290 | ||
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 5.40e-11 | 147 | 52 | 8 | 28977470 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | CASC3 FXR1 ILF2 G3BP1 RBMXL1 ATXN2 RBMX DHX57 EWSR1 NCL PURG | 7.47e-11 | 462 | 52 | 11 | 31138677 |
| Pubmed | FXR1 ILF2 G3BP1 ATXN2 FBL SUPT5H RBMX DHX57 EWSR1 NCL TAF15 CHTOP | 9.11e-11 | 615 | 52 | 12 | 31048545 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 9.91e-11 | 349 | 52 | 10 | 25665578 | |
| Pubmed | 1.76e-10 | 260 | 52 | 9 | 36199071 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FXR1 ILF2 G3BP1 RBMXL1 ATXN2 FBL NOM1 RBMX EWSR1 NCL MECP2 CHTOP NUP153 METTL14 LRRC47 | 2.76e-10 | 1257 | 52 | 15 | 36526897 |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | NOP9 IRS4 FXR1 ILF2 ATXN2 FBL NOM1 RBMX DHX57 EWSR1 NCL TAF15 | 2.77e-10 | 678 | 52 | 12 | 30209976 |
| Pubmed | 6.08e-10 | 121 | 52 | 7 | 34029587 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 7.49e-10 | 430 | 52 | 10 | 38172120 | |
| Pubmed | Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. | 8.49e-10 | 30 | 52 | 5 | 15782174 | |
| Pubmed | SPOP attenuates migration and invasion of choriocarcinoma cells by promoting DHX9 degradation. | 1.01e-09 | 130 | 52 | 7 | 32905556 | |
| Pubmed | 1.19e-09 | 601 | 52 | 11 | 33658012 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.28e-09 | 605 | 52 | 11 | 28977666 | |
| Pubmed | IRS4 ILF2 G3BP1 FBL RBMX EWSR1 NCL TAF15 CHTOP NUP153 LRRC47 | 2.33e-09 | 641 | 52 | 11 | 36057605 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 2.42e-09 | 486 | 52 | 10 | 30940648 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NOP9 IRS4 FXR1 ILF2 G3BP1 FBL SUPT5H RBMX EWSR1 NCL TAF15 CHTOP NUP153 | 2.54e-09 | 1024 | 52 | 13 | 24711643 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | IRS4 FXR1 ILF2 G3BP1 RBMXL1 FBL NOM1 RBMX LSM4 EWSR1 NCL TAF15 DHX33 LRRC47 | 2.96e-09 | 1257 | 52 | 14 | 37317656 |
| Pubmed | 3.12e-09 | 245 | 52 | 8 | 35652658 | ||
| Pubmed | 3.15e-09 | 153 | 52 | 7 | 28225217 | ||
| Pubmed | NOP9 FXR1 ILF2 G3BP1 FBL NOM1 RBMX EWSR1 NCL TAF15 CHTOP NUP153 | 3.40e-09 | 847 | 52 | 12 | 35850772 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 4.67e-09 | 258 | 52 | 8 | 37794589 | |
| Pubmed | IRS4 FXR1 ILF2 G3BP1 FBL SUPT5H NOM1 RBMX DHX57 LSM4 EWSR1 NCL CHTOP RING1 | 6.36e-09 | 1335 | 52 | 14 | 29229926 | |
| Pubmed | ILF2 G3BP1 RBMXL1 FBL RBMX DHX57 LSM4 EWSR1 NCL TAF15 RRAS CHTOP NUP153 | 1.04e-08 | 1153 | 52 | 13 | 29845934 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 1.33e-08 | 759 | 52 | 11 | 35915203 | |
| Pubmed | 1.51e-08 | 52 | 52 | 5 | 26265008 | ||
| Pubmed | IRS4 FXR1 ILF2 G3BP1 ATXN2 FBL RBMX DHX57 LSM4 NCL NUP153 LRRC47 | 1.55e-08 | 971 | 52 | 12 | 33306668 | |
| Pubmed | 4.07e-08 | 655 | 52 | 10 | 35819319 | ||
| Pubmed | 4.25e-08 | 223 | 52 | 7 | 33731348 | ||
| Pubmed | 4.65e-08 | 347 | 52 | 8 | 16033648 | ||
| Pubmed | 6.25e-08 | 236 | 52 | 7 | 36339263 | ||
| Pubmed | 9.14e-08 | 74 | 52 | 5 | 33989516 | ||
| Pubmed | 1.13e-07 | 731 | 52 | 10 | 29298432 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 1.28e-07 | 949 | 52 | 11 | 36574265 | |
| Pubmed | ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | 1.83e-07 | 166 | 52 | 6 | 35687106 | |
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 2.04e-07 | 169 | 52 | 6 | 23084401 | |
| Pubmed | 2.04e-07 | 421 | 52 | 8 | 34650049 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | CASC3 IRS4 FXR1 ILF2 RBMXL1 ATXN2 FBL NOM1 RBMX DHX57 NCL TMEM214 ARMCX2 | 2.17e-07 | 1496 | 52 | 13 | 32877691 |
| Pubmed | CASC3 ATXN2 NOM1 DHX57 TMEM214 TAF15 ERMP1 DHX33 RRAS MBD2 MECP2 CHTOP METTL14 | 2.19e-07 | 1497 | 52 | 13 | 31527615 | |
| Pubmed | FXR1 ILF2 G3BP1 FBL RBMX EWSR1 NCL TAF15 CCDC9 CHTOP LRRC47 RING1 | 2.34e-07 | 1247 | 52 | 12 | 27684187 | |
| Pubmed | 2.42e-07 | 174 | 52 | 6 | 35031058 | ||
| Pubmed | 2.87e-07 | 809 | 52 | 10 | 32129710 | ||
| Pubmed | 3.70e-07 | 187 | 52 | 6 | 29777862 | ||
| Pubmed | 4.18e-07 | 463 | 52 | 8 | 34901782 | ||
| Pubmed | 4.23e-07 | 844 | 52 | 10 | 25963833 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOP9 ILF2 RBMXL1 SUPT5H RBMX DHX57 EWSR1 NCL TAF15 GPC2 MECP2 | 4.72e-07 | 1082 | 52 | 11 | 38697112 |
| Pubmed | 4.72e-07 | 195 | 52 | 6 | 19454010 | ||
| Pubmed | 6.33e-07 | 205 | 52 | 6 | 27976729 | ||
| Pubmed | 6.51e-07 | 491 | 52 | 8 | 36273042 | ||
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | 9.17e-07 | 704 | 52 | 9 | 32994395 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NOP9 IRS4 FXR1 ILF2 G3BP1 FBL SUPT5H RBMX NCL CHTOP NUP153 LRRC47 | 9.64e-07 | 1425 | 52 | 12 | 30948266 |
| Pubmed | 1.03e-06 | 223 | 52 | 6 | 20020773 | ||
| Pubmed | 1.16e-06 | 123 | 52 | 5 | 35583604 | ||
| Pubmed | 1.17e-06 | 725 | 52 | 9 | 27025967 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 1.20e-06 | 533 | 52 | 8 | 30554943 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.28e-06 | 954 | 52 | 10 | 36373674 | |
| Pubmed | 1.39e-06 | 963 | 52 | 10 | 28671696 | ||
| Pubmed | Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. | 1.65e-06 | 57 | 52 | 4 | 17932509 | |
| Pubmed | 1.74e-06 | 244 | 52 | 6 | 30349055 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 1.77e-06 | 989 | 52 | 10 | 36424410 | |
| Pubmed | 1.78e-06 | 245 | 52 | 6 | 21182205 | ||
| Pubmed | 1.90e-06 | 136 | 52 | 5 | 21280222 | ||
| Pubmed | 2.05e-06 | 138 | 52 | 5 | 30320910 | ||
| Pubmed | 2.13e-06 | 399 | 52 | 7 | 35987950 | ||
| Pubmed | Localization of fibrillarin and nucleolin in nucleoli of mouse preimplantation embryos. | 2.19e-06 | 2 | 52 | 2 | 7772340 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 21420494 | ||
| Pubmed | A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. | 2.19e-06 | 2 | 52 | 2 | 11242117 | |
| Pubmed | Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. | 2.19e-06 | 2 | 52 | 2 | 22454397 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 22909121 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 15939760 | ||
| Pubmed | Components of the DNA methylation system of chromatin control are RNA-binding proteins. | 2.19e-06 | 2 | 52 | 2 | 15342650 | |
| Pubmed | Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. | 2.19e-06 | 2 | 52 | 2 | 14633992 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 23335972 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 8954779 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 35810559 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 2.34e-06 | 583 | 52 | 8 | 29844126 | |
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | 2.35e-06 | 1021 | 52 | 10 | 26760575 | |
| Pubmed | 2.35e-06 | 142 | 52 | 5 | 30217970 | ||
| Pubmed | The EGFR-ZNF263 signaling axis silences SIX3 in glioblastoma epigenetically. | 2.99e-06 | 66 | 52 | 4 | 32051553 | |
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 3.26e-06 | 272 | 52 | 6 | 25315684 | |
| Pubmed | TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas. | 3.29e-06 | 152 | 52 | 5 | 28192407 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 3.95e-06 | 626 | 52 | 8 | 33644029 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 4.05e-06 | 440 | 52 | 7 | 34244565 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 4.09e-06 | 283 | 52 | 6 | 30585729 | |
| Pubmed | Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus. | 4.10e-06 | 159 | 52 | 5 | 34578187 | |
| Pubmed | 4.10e-06 | 159 | 52 | 5 | 22751105 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 4.13e-06 | 1353 | 52 | 11 | 29467282 | |
| Pubmed | 4.35e-06 | 286 | 52 | 6 | 32041737 | ||
| Pubmed | 4.54e-06 | 638 | 52 | 8 | 33239621 | ||
| Pubmed | 5.32e-06 | 652 | 52 | 8 | 31180492 | ||
| Pubmed | 5.47e-06 | 23 | 52 | 3 | 20696395 | ||
| Interaction | ELAVL2 interactions | 3.60e-11 | 188 | 51 | 10 | int:ELAVL2 | |
| Interaction | PRMT1 interactions | IRS4 FXR1 ILF2 G3BP1 ATXN2 FBL SUPT5H RBMX EWSR1 NCL TAF15 MBD2 TUSC1 MECP2 CCDC9 CHTOP METTL14 | 5.58e-11 | 929 | 51 | 17 | int:PRMT1 |
| Interaction | SNRNP70 interactions | CASC3 FXR1 ILF2 G3BP1 RBMXL1 ATXN2 FBL RBMX DHX57 LSM4 EWSR1 NCL TAF15 MECP2 CCDC9 CHTOP METTL14 | 1.36e-10 | 984 | 51 | 17 | int:SNRNP70 |
| Interaction | MYCN interactions | CASC3 IRS4 FXR1 ILF2 G3BP1 RBMXL1 ATXN2 FBL NOM1 RBMX DHX57 LSM4 EWSR1 NCL TAF15 MECP2 CCDC9 CHTOP RING1 | 3.57e-10 | 1373 | 51 | 19 | int:MYCN |
| Interaction | DDX5 interactions | FXR1 ILF2 G3BP1 ATXN2 FBL SUPT5H RBMX EWSR1 NCL TAF15 MBD6 MECP2 METTL14 | 1.10e-09 | 568 | 51 | 13 | int:DDX5 |
| Interaction | WDR77 interactions | FXR1 ILF2 G3BP1 FBL SUPT5H LSM4 NCL TAF15 MBD2 CHTOP METTL14 | 1.31e-09 | 361 | 51 | 11 | int:WDR77 |
| Interaction | RBM8A interactions | CASC3 NOP9 ILF2 ATXN2 SUPT5H RBMX DHX57 EWSR1 NCL MECP2 CCDC9 CHTOP | 1.68e-09 | 473 | 51 | 12 | int:RBM8A |
| Interaction | ILF2 interactions | CASC3 FXR1 ILF2 RBMXL1 ATXN2 SUPT5H RBMX EWSR1 NCL TAF15 MECP2 METTL14 KIF1C | 1.75e-09 | 590 | 51 | 13 | int:ILF2 |
| Interaction | TDRD3 interactions | 2.76e-09 | 212 | 51 | 9 | int:TDRD3 | |
| Interaction | SRSF3 interactions | CASC3 ILF2 G3BP1 RBMXL1 RBMX EWSR1 NCL TAF15 MBD6 MECP2 CCDC9 METTL14 | 5.09e-09 | 522 | 51 | 12 | int:SRSF3 |
| Interaction | BMI1 interactions | CASC3 FXR1 ILF2 G3BP1 ATXN2 FBL PAK4 EWSR1 NCL TAF15 MBD2 CHTOP RING1 | 6.59e-09 | 659 | 51 | 13 | int:BMI1 |
| Interaction | WDR5 interactions | FXR1 ILF2 G3BP1 RBMXL1 FBL RBMX LSM4 EWSR1 NCL TMEM214 TAF15 ERMP1 MBD6 CHTOP LRRC47 RING1 | 6.62e-09 | 1101 | 51 | 16 | int:WDR5 |
| Interaction | DDX17 interactions | ILF2 ATXN2 FBL SUPT5H RBMX EWSR1 NCL TAF15 MBD6 MECP2 METTL14 | 7.37e-09 | 426 | 51 | 11 | int:DDX17 |
| Interaction | RC3H2 interactions | NOP9 IRS4 FXR1 ILF2 G3BP1 ATXN2 FBL NOM1 RBMX DHX57 EWSR1 NCL TAF15 | 7.61e-09 | 667 | 51 | 13 | int:RC3H2 |
| Interaction | SRSF1 interactions | CASC3 FXR1 ILF2 RBMXL1 RBMX DHX57 EWSR1 NCL TAF15 MBD6 MECP2 METTL14 | 1.36e-08 | 570 | 51 | 12 | int:SRSF1 |
| Interaction | SNRPD1 interactions | 1.37e-08 | 347 | 51 | 10 | int:SNRPD1 | |
| Interaction | FAM120A interactions | 1.45e-08 | 349 | 51 | 10 | int:FAM120A | |
| Interaction | DDX21 interactions | CASC3 ILF2 G3BP1 FBL RBMX DHX57 NCL TAF15 MECP2 CHTOP NUP153 PURG METTL14 | 1.83e-08 | 718 | 51 | 13 | int:DDX21 |
| Interaction | SYNCRIP interactions | ILF2 G3BP1 RBMXL1 ATXN2 FBL DHX57 LSM4 EWSR1 NCL TAF15 MECP2 PURG METTL14 | 1.92e-08 | 721 | 51 | 13 | int:SYNCRIP |
| Interaction | RPS16 interactions | CASC3 NOP9 FXR1 ILF2 ATXN2 FBL DHX57 NCL MBD6 MECP2 PURG METTL14 LRRC47 | 2.01e-08 | 724 | 51 | 13 | int:RPS16 |
| Interaction | ZC3H18 interactions | IRS4 ILF2 G3BP1 RBMXL1 FBL SUPT5H RBMX LSM4 EWSR1 NCL TAF15 MECP2 CHTOP PURG | 2.27e-08 | 877 | 51 | 14 | int:ZC3H18 |
| Interaction | SIRT7 interactions | IRS4 FXR1 ILF2 G3BP1 FBL SUPT5H RBMX DHX57 EWSR1 NCL TAF15 NUP153 LRRC47 | 2.78e-08 | 744 | 51 | 13 | int:SIRT7 |
| Interaction | KHDRBS2 interactions | 3.42e-08 | 129 | 51 | 7 | int:KHDRBS2 | |
| Interaction | RPS8 interactions | NOP9 ILF2 G3BP1 ATXN2 FBL NOM1 DHX57 NCL MBD6 MECP2 PURG METTL14 | 5.65e-08 | 649 | 51 | 12 | int:RPS8 |
| Interaction | TARDBP interactions | ILF2 G3BP1 ATXN2 FBL RBMX DHX57 EWSR1 NCL TAF15 MECP2 METTL14 | 5.69e-08 | 520 | 51 | 11 | int:TARDBP |
| Interaction | LARP7 interactions | IRS4 ILF2 G3BP1 RBMXL1 FBL RBMX DHX57 LSM4 EWSR1 NCL TAF15 RRAS CHTOP NUP153 PURG | 6.02e-08 | 1113 | 51 | 15 | int:LARP7 |
| Interaction | CPSF6 interactions | FXR1 ILF2 G3BP1 SUPT5H RBMX LSM4 EWSR1 TAF15 MECP2 CHTOP METTL14 | 6.39e-08 | 526 | 51 | 11 | int:CPSF6 |
| Interaction | CASC3 interactions | 6.64e-08 | 142 | 51 | 7 | int:CASC3 | |
| Interaction | HNRNPR interactions | 7.73e-08 | 536 | 51 | 11 | int:HNRNPR | |
| Interaction | SRSF7 interactions | CASC3 FXR1 ILF2 RBMXL1 EWSR1 TAF15 MECP2 CCDC9 METTL14 KIF1C | 9.24e-08 | 425 | 51 | 10 | int:SRSF7 |
| Interaction | KHDRBS3 interactions | 1.33e-07 | 94 | 51 | 6 | int:KHDRBS3 | |
| Interaction | MEPCE interactions | ILF2 G3BP1 RBMXL1 FBL RBMX DHX57 LSM4 EWSR1 NCL TAF15 RRAS MECP2 CHTOP | 1.48e-07 | 859 | 51 | 13 | int:MEPCE |
| Interaction | YTHDF3 interactions | 1.78e-07 | 246 | 51 | 8 | int:YTHDF3 | |
| Interaction | RPS6 interactions | NOP9 FXR1 ILF2 G3BP1 ATXN2 FBL NOM1 DHX57 NCL DHX33 MECP2 PURG METTL14 | 1.81e-07 | 874 | 51 | 13 | int:RPS6 |
| Interaction | EP300 interactions | CASC3 ZNF469 NOP9 FXR1 ILF2 G3BP1 SUPT5H RBMX DHX57 EWSR1 TAF15 MN1 MECP2 CCDC9 CHTOP RING1 | 1.91e-07 | 1401 | 51 | 16 | int:EP300 |
| Interaction | HNRNPUL1 interactions | 2.13e-07 | 351 | 51 | 9 | int:HNRNPUL1 | |
| Interaction | RALY interactions | 2.40e-07 | 356 | 51 | 9 | int:RALY | |
| Interaction | CIT interactions | NOP9 ZNF142 FXR1 ILF2 G3BP1 RBMXL1 FBL SUPT5H RBMX DHX57 LSM4 NCL TMEM214 TAF15 NUP153 RING1 | 3.05e-07 | 1450 | 51 | 16 | int:CIT |
| Interaction | MAGOH interactions | 3.05e-07 | 264 | 51 | 8 | int:MAGOH | |
| Interaction | HNRNPAB interactions | 3.39e-07 | 371 | 51 | 9 | int:HNRNPAB | |
| Interaction | HNRNPC interactions | CASC3 ILF2 RBMXL1 SUPT5H RBMX TAF15 MBD2 MECP2 CCDC9 PURG METTL14 | 4.15e-07 | 634 | 51 | 11 | int:HNRNPC |
| Interaction | SRSF6 interactions | 4.38e-07 | 503 | 51 | 10 | int:SRSF6 | |
| Interaction | CSDE1 interactions | 5.31e-07 | 284 | 51 | 8 | int:CSDE1 | |
| Interaction | DDX3X interactions | 5.40e-07 | 651 | 51 | 11 | int:DDX3X | |
| Interaction | PSPC1 interactions | 5.43e-07 | 515 | 51 | 10 | int:PSPC1 | |
| Interaction | RPS3A interactions | 5.73e-07 | 655 | 51 | 11 | int:RPS3A | |
| Interaction | SAFB2 interactions | 5.76e-07 | 195 | 51 | 7 | int:SAFB2 | |
| Interaction | PRC1 interactions | FXR1 ILF2 G3BP1 RBMXL1 FBL RBMX ADGRB2 NCL TAF15 DHX33 MN1 MECP2 NUP153 | 6.16e-07 | 973 | 51 | 13 | int:PRC1 |
| Interaction | FMR1 interactions | 7.81e-07 | 536 | 51 | 10 | int:FMR1 | |
| Interaction | RC3H1 interactions | 7.94e-07 | 677 | 51 | 11 | int:RC3H1 | |
| Interaction | EIF4ENIF1 interactions | 8.02e-07 | 300 | 51 | 8 | int:EIF4ENIF1 | |
| Interaction | RPL31 interactions | ILF2 G3BP1 FBL SUPT5H NOM1 RBMX DHX57 EWSR1 NCL DHX33 METTL14 | 8.29e-07 | 680 | 51 | 11 | int:RPL31 |
| Interaction | PNN interactions | 8.44e-07 | 302 | 51 | 8 | int:PNN | |
| Interaction | RBM45 interactions | 8.60e-07 | 207 | 51 | 7 | int:RBM45 | |
| Interaction | WWP2 interactions | FXR1 ILF2 G3BP1 ATXN2 FBL SUPT5H RBMX DHX57 EWSR1 NCL TAF15 CHTOP | 9.00e-07 | 840 | 51 | 12 | int:WWP2 |
| Interaction | THOC1 interactions | 9.47e-07 | 210 | 51 | 7 | int:THOC1 | |
| Interaction | HDLBP interactions | FXR1 ILF2 G3BP1 FBL RBMX DHX57 EWSR1 TAF15 CHTOP METTL14 LRRC47 RING1 | 1.08e-06 | 855 | 51 | 12 | int:HDLBP |
| Interaction | RIOK1 interactions | 1.20e-06 | 562 | 51 | 10 | int:RIOK1 | |
| Interaction | CLK3 interactions | 1.29e-06 | 220 | 51 | 7 | int:CLK3 | |
| Interaction | NOP56 interactions | 1.36e-06 | 570 | 51 | 10 | int:NOP56 | |
| Interaction | SNRPC interactions | 1.40e-06 | 440 | 51 | 9 | int:SNRPC | |
| Interaction | PURG interactions | 1.42e-06 | 223 | 51 | 7 | int:PURG | |
| Interaction | SRSF9 interactions | 1.46e-06 | 224 | 51 | 7 | int:SRSF9 | |
| Interaction | THRAP3 interactions | 1.48e-06 | 443 | 51 | 9 | int:THRAP3 | |
| Interaction | UPF1 interactions | 1.62e-06 | 581 | 51 | 10 | int:UPF1 | |
| Interaction | SRP72 interactions | 1.75e-06 | 333 | 51 | 8 | int:SRP72 | |
| Interaction | TERF2 interactions | 2.05e-06 | 340 | 51 | 8 | int:TERF2 | |
| Interaction | MYBBP1A interactions | 2.13e-06 | 463 | 51 | 9 | int:MYBBP1A | |
| Interaction | HEXIM1 interactions | ILF2 G3BP1 RBMXL1 RBMX DHX57 LSM4 EWSR1 NCL TAF15 RRAS MECP2 CHTOP | 2.15e-06 | 913 | 51 | 12 | int:HEXIM1 |
| Interaction | R3HDM1 interactions | 2.25e-06 | 84 | 51 | 5 | int:R3HDM1 | |
| Interaction | LARP4B interactions | 2.31e-06 | 240 | 51 | 7 | int:LARP4B | |
| Interaction | PRMT5 interactions | 2.45e-06 | 471 | 51 | 9 | int:PRMT5 | |
| Interaction | NCBP1 interactions | 2.70e-06 | 353 | 51 | 8 | int:NCBP1 | |
| Interaction | SRPK1 interactions | 2.72e-06 | 477 | 51 | 9 | int:SRPK1 | |
| Interaction | CHD4 interactions | ILF2 G3BP1 FBL SUPT5H NOM1 RBMX EWSR1 NCL TAF15 MBD2 MECP2 CHTOP | 2.85e-06 | 938 | 51 | 12 | int:CHD4 |
| Interaction | C9orf72 interactions | IRS4 FXR1 ILF2 G3BP1 RBMXL1 FBL NOM1 RBMX LSM4 EWSR1 NCL TAF15 DHX33 LRRC47 | 3.23e-06 | 1319 | 51 | 14 | int:C9orf72 |
| Interaction | SPOP interactions | 3.44e-06 | 491 | 51 | 9 | int:SPOP | |
| Interaction | UBE2O interactions | 3.55e-06 | 790 | 51 | 11 | int:UBE2O | |
| Interaction | DDX50 interactions | 3.63e-06 | 257 | 51 | 7 | int:DDX50 | |
| Interaction | BRD7 interactions | 3.68e-06 | 637 | 51 | 10 | int:BRD7 | |
| Interaction | EIF4A3 interactions | 3.93e-06 | 499 | 51 | 9 | int:EIF4A3 | |
| Interaction | LYAR interactions | 4.06e-06 | 373 | 51 | 8 | int:LYAR | |
| Interaction | DHX15 interactions | 4.12e-06 | 502 | 51 | 9 | int:DHX15 | |
| Interaction | DDX6 interactions | 4.19e-06 | 503 | 51 | 9 | int:DDX6 | |
| Interaction | U2AF2 interactions | 4.46e-06 | 651 | 51 | 10 | int:U2AF2 | |
| Interaction | SNRPD3 interactions | 4.66e-06 | 380 | 51 | 8 | int:SNRPD3 | |
| Interaction | MATR3 interactions | 4.71e-06 | 655 | 51 | 10 | int:MATR3 | |
| Interaction | CCDC8 interactions | 4.77e-06 | 656 | 51 | 10 | int:CCDC8 | |
| Interaction | FZR1 interactions | IRS4 FXR1 ILF2 G3BP1 ATXN2 FBL RBMX DHX57 LSM4 E2F3 NCL NUP153 LRRC47 | 4.88e-06 | 1172 | 51 | 13 | int:FZR1 |
| Interaction | RPLP0 interactions | 5.03e-06 | 660 | 51 | 10 | int:RPLP0 | |
| Interaction | RPS9 interactions | 5.07e-06 | 515 | 51 | 9 | int:RPS9 | |
| Interaction | SNRPF interactions | 5.12e-06 | 385 | 51 | 8 | int:SNRPF | |
| Interaction | SNRPB interactions | 5.23e-06 | 517 | 51 | 9 | int:SNRPB | |
| Interaction | G3BP2 interactions | 5.32e-06 | 518 | 51 | 9 | int:G3BP2 | |
| Interaction | PRRC2A interactions | 5.53e-06 | 389 | 51 | 8 | int:PRRC2A | |
| Interaction | CIC interactions | 5.98e-06 | 673 | 51 | 10 | int:CIC | |
| Interaction | AGO1 interactions | 6.63e-06 | 183 | 51 | 6 | int:AGO1 | |
| Interaction | RECQL4 interactions | IRS4 FXR1 ILF2 G3BP1 FBL SUPT5H NOM1 RBMX DHX57 LSM4 EWSR1 NCL CHTOP RING1 | 7.11e-06 | 1412 | 51 | 14 | int:RECQL4 |
| Interaction | UFL1 interactions | IRS4 FXR1 ILF2 G3BP1 FBL RBMX DHX57 EWSR1 NCL MECP2 METTL14 LRRC47 | 7.51e-06 | 1031 | 51 | 12 | int:UFL1 |
| Interaction | RNF113A interactions | 7.63e-06 | 692 | 51 | 10 | int:RNF113A | |
| Cytoband | 17q21.1 | 2.36e-04 | 20 | 52 | 2 | 17q21.1 | |
| Cytoband | 17p13.2 | 1.80e-03 | 55 | 52 | 2 | 17p13.2 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 8.23e-07 | 11 | 32 | 3 | 1025 | |
| GeneFamily | RNA binding motif containing | 1.75e-06 | 213 | 32 | 6 | 725 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 6.55e-06 | 21 | 32 | 3 | 89 | |
| GeneFamily | DEAH-box helicases | 3.59e-04 | 16 | 32 | 2 | 500 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | CASC3 NOP9 ILF2 G3BP1 FBL LSM4 NCL MBD2 MECP2 CHTOP NUP153 RING1 | 1.61e-06 | 1129 | 52 | 12 | M42508 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | CASC3 NOP9 ILF2 G3BP1 FBL LSM4 NCL MBD2 MECP2 CHTOP NUP153 RING1 | 2.09e-06 | 1158 | 52 | 12 | MM1338 |
| Coexpression | MUELLER_PLURINET | 2.75e-05 | 299 | 52 | 6 | M123 | |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 3.21e-05 | 184 | 52 | 5 | M19988 | |
| Coexpression | GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP | 4.56e-05 | 198 | 52 | 5 | M9534 | |
| Coexpression | GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN | 4.67e-05 | 199 | 52 | 5 | M7099 | |
| Coexpression | GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_UP | 4.78e-05 | 200 | 52 | 5 | M6456 | |
| Coexpression | GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_DN | 4.78e-05 | 200 | 52 | 5 | M4338 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | 8.09e-05 | 1407 | 52 | 11 | M14427 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | 1.18e-04 | 761 | 52 | 8 | M11961 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | 1.24e-04 | 568 | 52 | 7 | M4023 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN | 1.93e-04 | 1045 | 52 | 9 | M8525 | |
| Coexpression | HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER | 2.00e-04 | 57 | 52 | 3 | M9044 | |
| Coexpression | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22 | 2.10e-04 | 11 | 52 | 2 | M11594 | |
| CoexpressionAtlas | MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst-Confounder_removed-fold2.0_adjp0.05 | CASC3 RBMXL1 TSPOAP1 FBL RBMX DHX57 E2F3 DHX33 GPC2 GPR162 MN1 NUP153 SOCS7 | 2.68e-05 | 1479 | 50 | 13 | PCBC_ratio_MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst_cfr-2X-p05 |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.53e-08 | 188 | 52 | 6 | 8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc | |
| ToppCell | HSPCs|World / Lineage and Cell class | 3.53e-06 | 199 | 52 | 5 | df1ffc416c6946f1ba182f242a50ee41a571d565 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.77e-05 | 180 | 52 | 4 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 190 | 52 | 4 | 933c778bb8ec89621906fe7d484c1d2c6cd28d80 | |
| ToppCell | E12.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.72e-05 | 194 | 52 | 4 | 4b335e4da58de1cd94194dc4208ce83854e5e50a | |
| ToppCell | control-Others-CD34+_GATA2+_cells|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.03e-05 | 196 | 52 | 4 | 25994ca143701c72d2f84a3b6d348fcfa1d26a54 | |
| ToppCell | mild-Others-CD34+_GATA2+_cells|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.19e-05 | 197 | 52 | 4 | a375edbc885ae069f9abcd8d5886fdaa8913f83d | |
| ToppCell | CV-Severe-2|Severe / Virus stimulation, Condition and Cluster | 8.35e-05 | 198 | 52 | 4 | 254659bb53dc2511c714295c2df1ab1fddb2f867 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.51e-05 | 199 | 52 | 4 | ea75804c34989c99aab542e6d72617ed144819b6 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 8.51e-05 | 199 | 52 | 4 | 6f159c1215439ec22374903124085746fa8da333 | |
| ToppCell | CD8+_Memory_T_cell-CV-2|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.51e-05 | 199 | 52 | 4 | 1e33d8e2e0d6a54ef6e2e13f986e19fd209275a8 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.51e-05 | 199 | 52 | 4 | 713dfd8552635645db5e0b5721c64e5c9b4aa06c | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 8.51e-05 | 199 | 52 | 4 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | CV-Moderate-2|CV / Virus stimulation, Condition and Cluster | 8.51e-05 | 199 | 52 | 4 | 2d98424a5247e87f98095c11fb945289092a9d75 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm|5w / Sample Type, Dataset, Time_group, and Cell type. | 8.68e-05 | 200 | 52 | 4 | 0927061536a664b4f7feb9e5b0a8c11ca0d5955c | |
| ToppCell | 5'-GW_trimst-1|5' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.68e-05 | 200 | 52 | 4 | a4c6d0cccba7aee35eaedf29faff32b9494b6582 | |
| Computational | Neighborhood of MLH1 | 8.58e-06 | 42 | 34 | 4 | GNF2_MLH1 | |
| Computational | Neighborhood of FBL | 7.16e-05 | 140 | 34 | 5 | MORF_FBL | |
| Computational | Neighborhood of KPNB1 | 7.78e-05 | 73 | 34 | 4 | GNF2_KPNB1 | |
| Computational | Neighborhood of PCNA | 1.28e-04 | 83 | 34 | 4 | MORF_PCNA | |
| Computational | Neighborhood of TDG | 1.77e-04 | 35 | 34 | 3 | GNF2_TDG | |
| Computational | Neighborhood of APEX1 | 1.91e-04 | 92 | 34 | 4 | GNF2_APEX1 | |
| Computational | Neighborhood of ANP32B | 1.92e-04 | 36 | 34 | 3 | GCM_ANP32B | |
| Computational | Neighborhood of DEK | 7.92e-04 | 58 | 34 | 3 | GNF2_DEK | |
| Computational | TFs and nuclear. | 8.24e-04 | 237 | 34 | 5 | MODULE_252 | |
| Computational | Genes in the cancer module 32. | 8.89e-04 | 241 | 34 | 5 | MODULE_32 | |
| Computational | Neighborhood of RPA1 | 9.18e-04 | 61 | 34 | 3 | MORF_RPA1 | |
| Computational | Neighborhood of SMC1L1 | 9.63e-04 | 62 | 34 | 3 | MORF_SMC1L1 | |
| Computational | Genes in the cancer module 98. | 1.30e-03 | 393 | 34 | 6 | MODULE_98 | |
| Computational | Neighborhood of NPM1 | 1.49e-03 | 72 | 34 | 3 | GNF2_NPM1 | |
| Computational | Neighborhood of BUB3 | 1.65e-03 | 277 | 34 | 5 | MORF_BUB3 | |
| Computational | Neighborhood of XRCC5 | 1.67e-03 | 75 | 34 | 3 | GNF2_XRCC5 | |
| Computational | Neighborhood of SOD1 | 1.68e-03 | 278 | 34 | 5 | MORF_SOD1 | |
| Computational | Neighborhood of G22P1 | 2.02e-03 | 172 | 34 | 4 | MORF_G22P1 | |
| Computational | Genes in the cancer module 198. | 2.45e-03 | 303 | 34 | 5 | MODULE_198 | |
| Computational | Neighborhood of SMC1L1 | 3.24e-03 | 27 | 34 | 2 | GNF2_SMC1L1 | |
| Computational | Neighborhood of RPA1 | 3.49e-03 | 28 | 34 | 2 | GNF2_RPA1 | |
| Disease | amyotrophic lateral sclerosis type 6 (implicated_via_orthology) | 8.78e-06 | 3 | 51 | 2 | DOID:0060198 (implicated_via_orthology) | |
| Disease | Extraskeletal Myxoid Chondrosarcoma | 2.92e-05 | 5 | 51 | 2 | C1275278 | |
| Disease | Amyotrophic Lateral Sclerosis | 1.40e-04 | 58 | 51 | 3 | C0002736 | |
| Disease | frontotemporal dementia (implicated_via_orthology) | 1.91e-04 | 12 | 51 | 2 | DOID:9255 (implicated_via_orthology) | |
| Disease | bipolar disorder, sex interaction measurement | 4.40e-04 | 18 | 51 | 2 | EFO_0008343, MONDO_0004985 | |
| Disease | eye measurement | 1.00e-03 | 27 | 51 | 2 | EFO_0004731 | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 1.24e-03 | 30 | 51 | 2 | DOID:332 (implicated_via_orthology) | |
| Disease | interleukin 2 receptor antagonist measurement | 1.68e-03 | 35 | 51 | 2 | EFO_0008332 | |
| Disease | Mitral valve prolapse | 1.78e-03 | 36 | 51 | 2 | HP_0001634 | |
| Disease | spleen volume | 2.53e-03 | 43 | 51 | 2 | EFO_0600047 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RRTLSLQPGGGGGGG | 1356 | O60241 | |
| GRRGGRGGPGKMDKG | 631 | Q01844 | |
| TGRGKPRLGGGSGLG | 6 | Q6P575 | |
| GGRTRKRSPGGSGGA | 46 | Q7Z2K6 | |
| KRSPGGSGGASRGAG | 51 | Q7Z2K6 | |
| GGGKGVTRSRNGGKG | 281 | Q7L311 | |
| RGRGGFQGRGGDPKS | 341 | Q92804 | |
| GGRGGSGGTRGPPSR | 111 | P38159 | |
| MPGLVGGSSRRRGGG | 1396 | O95153 | |
| GRGSGKRGRRGGGGL | 851 | Q96DN6 | |
| PAGGKRGRGAKGSGR | 16 | Q86U38 | |
| KGGGGGRAGGPERRT | 36 | Q6DN14 | |
| ARRVGGGGGTKAGGP | 216 | Q16538 | |
| RRDGSGGKGGGGSAR | 531 | Q8N158 | |
| GGRGRGGPRGGKSSI | 451 | P51114 | |
| GGRGGGKGKGRAEGS | 261 | Q8N1G4 | |
| GAPRGGGRGGTSAGR | 411 | Q9HCE5 | |
| GGGRPGLGRGRNSNK | 236 | Q99700 | |
| SGGNRGRGRGGKRGN | 66 | P22087 | |
| GLQGSGGRGGGLRRP | 951 | O43896 | |
| KPKGEGGFGGRGGGR | 646 | P19338 | |
| GRGRGRPPSGGSGLG | 91 | Q9UBB5 | |
| GGGGSGSLPSQRGGR | 41 | O15234 | |
| RGGSGGGGGPPAKRR | 121 | O00716 | |
| PGEQPRGGGAGGRGR | 116 | Q9Y3X0 | |
| NRLRGPGGPRGGLGG | 426 | Q13283 | |
| PGKGGGKGSSRGGRG | 11 | Q6P158 | |
| GRFGSRGGPGGGFRP | 11 | Q12905 | |
| GGRGGGGGRRQQPPL | 41 | Q9H6R0 | |
| VFGGRGRGGIPGTGR | 111 | Q9Y4Z0 | |
| GGGGATGGSPGERKR | 131 | Q8NEL9 | |
| KRPRGGGAGGSSVGT | 201 | Q06587 | |
| RGGPGKAGSRGRFAG | 126 | O96013 | |
| RRGGGGGRGRGGKNV | 6 | Q9UJV8 | |
| GGTGGKGKSGGRFRL | 641 | O14654 | |
| APGTGRGRGRPKGSG | 181 | P51608 | |
| DGKPVSGGGGRGRGR | 931 | Q10571 | |
| PRGFGAGRGGSGGTR | 106 | Q96E39 | |
| AGRGGSGGTRGPPSR | 111 | Q96E39 | |
| RSVRLGGPGGGAGGA | 91 | Q14934 | |
| GGRGPRRGPAGGGEK | 26 | Q5C9Z4 | |
| SPGGGSGGMSRGRGR | 686 | O00267 | |
| VRGRGGPGRGGLGRG | 156 | Q9Y3Y2 | |
| IARGGGLGSRGPFGG | 6 | Q96NA8 | |
| KGRRPGVGAGAGGRG | 16 | Q6NUQ4 | |
| RRKSPGGGGGGGSGN | 186 | Q9NS37 | |
| GGVGGGGGGKIRTRR | 6 | P49790 | |
| ELSSPGRGGGGGGRL | 136 | O14512 | |
| GSGSGGGGRASGLRP | 966 | Q96JG9 | |
| GGRGGGGKRGTPQTQ | 1051 | P52746 | |
| ASGTGRGRPRGGGPG | 6 | P10301 | |
| GGGGGPAGGQRSLQR | 41 | Q9UHV5 | |
| RSGRARGGGSPSGGG | 31 | Q2TAM9 | |
| KRKRPRVAGGGGAGG | 71 | O60682 |